Turnstone Biologics (TSBX) Stock Price, News, Quotes-Moomoo

$Turnstone Biologics (TSBX.US)$
Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights
Turnstone Biologics Corp. (Nasdaq: TSBX) reported Q2 2024 financial results and business highlights. Key points include:
1. Positive initial data from Phase 1 trial of TIDAL-01 in metastatic colorectal cancer, with a 25% overall response rate and 50% disease control rate.
2. Cash position of $62.4 million, expected to fund operations into Q...

Jaguar8

Aug 14 15:03

NEWS

$Turnstone Biologics (TSBX.US)$
Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer
Turnstone Biologics Corp. (Nasdaq: TSBX) reported positive initial data from its Phase 1 STARLING trial of TIDAL-01 in metastatic microsatellite stable colorectal cancer (MSS mCRC). Key findings include:
- 25% overall response rate (ORR) and 50% disease control rate (DCR) among four evaluable patients
- One patient achieved a deep and durable o...

frogoracletrading

Jun 4 10:46

$TSBX Support / Resistance Levels

Continues to consolidating and tighten. Here are the levels to watch for the break to the upside.
Larger Image: tradingview.com...
$Turnstone Biologics (TSBX.US)$

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

TSBX Turnstone Biologics

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target